Aspect Partners’s Gilead Sciences GILD Stock Holding History

Aspect Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.4K	Hold	177	–	–	0.01%	192
2026 Q1	$24.7K	Hold	177	–	–	0.01%	171
2025 Q4	$21.7K	Buy	177 +15	+9%	+$1.82K	0.01%	188
2025 Q3	$18K	Sell	162 -160	-50%	-$18.2K	0.01%	237
2025 Q2	$35.7K	Buy	322 +156	+94%	+$16.6K	0.02%	172
2025 Q1	$18.6K	Buy	166 +7	+4%	+$722	0.01%	203
2024 Q4	$14.7K	Buy	159 +13	+9%	+$1.17K	0.01%	241
2024 Q3	$12.2K	Hold	146	–	–	0.01%	252
2024 Q2	$10K	Hold	146	–	–	0.01%	267
2024 Q1	$10.7K	Sell	146 -10	-6%	-$769	0.01%	261
2023 Q4	$12.6K	Buy	+156	New	+$12.1K	0.01%	231

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Aspect Partners's GILD Position: Q2 2026 in Review

Aspect Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 177 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #192.

Aspect Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $35.7K in Q2 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Aspect Partners held 177 shares of Gilead Sciences worth $22.4K as of Q2 2026.
Aspect Partners left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Aspect Partners's portfolio in Q2 2026, its #192 holding.
Aspect Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Aspect Partners's Gilead Sciences position peaked at $35.7K in Q2 2025.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.